Published in PLoS One on March 27, 2015
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest (2004) 11.84
Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet (2008) 9.10
Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial. Lancet (1960) 7.96
A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med (1999) 6.88
Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). JAMA (1990) 5.37
Natural history of venous thromboembolism. Circulation (2003) 3.67
Autopsy proven pulmonary embolism in hospital patients: are we detecting enough deep vein thrombosis? J R Soc Med (1989) 3.44
Incidence of venous thromboembolism verified by necropsy over 30 years. BMJ (1991) 3.14
Natural history of pulmonary embolism. Prog Cardiovasc Dis (1975) 2.83
Impact of the patient population on the risk for heparin-induced thrombocytopenia. Blood (2000) 2.78
Hemorrhagic complications of anticoagulant treatment. Chest (2001) 2.76
Frequent asymptomatic pulmonary embolism in patients with deep venous thrombosis. JAMA (1994) 2.72
Detection of pulmonary embolism in patients with unresolved clinical and scintigraphic diagnosis: helical CT versus angiography. AJR Am J Roentgenol (1995) 2.43
Performance of helical computed tomography in unselected outpatients with suspected pulmonary embolism. Ann Intern Med (2001) 2.11
Estimated annual numbers of US acute-care hospital patients at risk for venous thromboembolism. Am J Hematol (2007) 2.06
A 14-year study of heparin-induced thrombocytopenia. Am J Med (1996) 2.03
A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. The THESEE Study Group. Tinzaparine ou Heparine Standard: Evaluations dans l'Embolie Pulmonaire. N Engl J Med (1997) 1.97
Direct medical costs of venous thromboembolism and subsequent hospital readmission rates: an administrative claims analysis from 30 managed care organizations. J Manag Care Pharm (2007) 1.89
A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism: examining some unanswered questions regarding location of treatment, product type, and dosing frequency. Arch Intern Med (2000) 1.70
Cost effectiveness of thromboprophylaxis with a low-molecular-weight heparin versus unfractionated heparin in acutely ill medical inpatients. Am J Manag Care (2004) 1.69
Risk of fatal pulmonary embolism in patients with treated venous thromboembolism. JAMA (1998) 1.67
Prevention of venous thromboembolism in internal medicine with unfractionated or low-molecular-weight heparins: a meta-analysis of randomised clinical trials. Thromb Haemost (2000) 1.56
Surveillance for deep vein thrombosis and pulmonary embolism: recommendations from a national workshop. Am J Prev Med (2010) 1.55
Guidelines on the use and monitoring of heparin. Br J Haematol (2006) 1.51
Pulmonary embolism: diagnosis with contrast-enhanced electron-beam CT and comparison with pulmonary angiography. Radiology (1995) 1.49
Cost utility of substituting enoxaparin for unfractionated heparin for prophylaxis of venous thrombosis in the hospitalized medical patient. J Hosp Med (2006) 1.46
Recent trends in clinical outcomes and resource utilization for pulmonary embolism in the United States: findings from the nationwide inpatient sample. Chest (2009) 1.40
Current status of pulmonary thromboembolic disease: pathophysiology, diagnosis, prevention, and treatment. Am Heart J (1982) 1.34
Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients. Thromb Haemost (2005) 1.27
Pulmonary embolism and thrombophlebitis in the United States, 1970-1985. Am Heart J (1987) 1.21
Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease. Ann Intern Med (2001) 1.21
Unexpected high prevalence of silent pulmonary embolism in patients with deep venous thrombosis. Chest (1989) 1.20
The venous thrombotic risk in non-surgical patients: epidemiological data and efficacy/safety profile of a low-molecular-weight heparin (enoxaparin). The Prime Study Group. Haemostasis (1996) 1.09
Heparin-induced thrombocytopenia with thrombosis: incidence, analysis of risk factors, and clinical outcomes in 108 consecutive patients treated at a single institution. Am J Hematol (1997) 1.04
What hospital inpatient services contributed the most to the 2001-2006 growth in the cost per case? Health Serv Res (2012) 1.01
Lepirudin (recombinant hirudin) for parenteral anticoagulation in patients with heparin-induced thrombocytopenia. Heparin-Associated Thrombocytopenia Study (HAT) investigators. Circulation (1999) 1.01
Spiral computed tomography for the diagnosis of pulmonary embolism in critically ill surgical patients: a comparison with pulmonary angiography. Arch Surg (2001) 1.00
Clinically suspected pulmonary embolism: utility of spiral CT. Radiology (1999) 0.99
Subcutaneous low-molecular-weight heparin versus standard heparin and the prevention of thromboembolism in medical inpatients. The Heparin Study in Internal Medicine Group. Haemostasis (1996) 0.94
Economic burden of venous thromboembolism: a systematic review. J Med Econ (2011) 0.94
Cost-effectiveness of prolonged thromboprophylaxis after cancer surgery. Ann Surg Oncol (2009) 0.88
Bleeding complications with enoxaparin for deep venous thrombosis prophylaxis. J Arthroplasty (1999) 0.87
Comparison of the two-year outcomes and costs of prophylaxis in medical patients at risk of venous thromboembolism. Thromb Haemost (2008) 0.85
Comparison of duplex ultrasonography and venography in the diagnosis of deep venous thrombosis. Br J Surg (1991) 0.84
NICE guidance on reducing the risk of venous thromboembolism in patients admitted to hospital. J R Soc Med (2010) 0.83
"False negatives" and "false positives" in acute pulmonary embolism: a clinical-postmortem comparison. Cardiologia (1997) 0.81
Accuracy of CT angiography versus pulmonary angiography in the diagnosis of acute pulmonary embolism: evaluation of the literature with summary ROC curve analysis. Acad Radiol (2000) 0.79
Predictive power of clinical symptoms in patients with presumptive deep venous thrombosis. Am J Phys Med Rehabil (1997) 0.78
Early experience using duplex ultrasonography in the diagnosis of deep venous thrombosis; a prospective evaluation. Ulster Med J (1999) 0.78
Duplex ultrasound diagnosis of symptomatic proximal deep vein thrombosis of lower limbs. Eur J Radiol (1992) 0.78
[Is clinical diagnosis of deep venous thrombosis really unreliable?]. J Mal Vasc (1993) 0.76
The Incidence of Heparin-Induced Thrombocytopenias Int J Angiol (1998) 0.76